Chemed Q4 2022 adjusted EPS $5.39 (+2.7% YoY); guides 2023 adjusted EPS $20.75-$21.10

CHEMED CORP

2022-FY EPS reported $16.53 revenue$2,134,963,000

Consolidated revenue $547M (+1.0% YoY); GAAP diluted EPS $4.13; adjusted diluted EPS $5.39.
VITAS net patient revenue $308M (-2.5%); ADC 17,434 (-2.8%); admissions -8.7%; adjusted EBITDA margin 19.8% (-189bps).
Roto-Rooter revenue $239M (+6.1%); adjusted EBITDA $69.3M (+11.4%); margin 29.0% (+138bps).
2023 guidance: VITAS revenue +6-7%, ADC +3.5-4%; Roto-Rooter revenue +5-5.5%; adjusted EPS $20.75-$21.10.
Share repurchases: 25,000 shares for $13.0M in Q4; $88M remaining authorization.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CHEMED CORP reported the fourth quarter ended December 31, 2022 results: revenue $547 million, EPS $4.13. Guidance initiated.

Period: the fourth quarter ended December 31, 2022
Revenue: $547 million
EPS: $4.13
Guidance: initiated
Result: reported results

Exact text from the filing

Chemed Corporation (Chemed) (NYSE: CHE ), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: · Revenue increased 1.0% to $547 million · GAAP Diluted Earnings-per-Share (EPS) of $4.13 · Adjusted Diluted EPS of $5.39

View on SEC.gov

Browse all earnings releases →

CHEMED CORP filing history →

Source: SEC EDGAR

accession 0001562762-23-000053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.